Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia

Journal of Infectious Diseases

Volumn 178, Issue 4, 1998, Pages 1000-1007

  Gendelman, Howard E ^b   Zheng, Jialin ^b   Coulter, Cynthia L ^b   Ghorpade, Anuja ^b   Che, Myhanh ^b   Thylin, Michael ^b   Rubocki, Ronald ^b   Persidsky, Yuri ^b   Hahn, Francis ^b   Reinhard Jr , John ^b   Swindells, Susan ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; DEMENTIA; DRUG INDICATION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLIC ENCEPHALOPATHY; NEUROTOXICITY; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION;

EID: 17344362228     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515693     Document Type: Article

References (24)

1. The Dana Consortium on Therapy. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1 associated cognitive/motor disorder. Neurology 1996;47:1247-54.
2. Lipton SA, Gendelman HE. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332:934-40.
3. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. clinical features. Ann Neurol 1986;19:517-24.
4. McArthur JC, Seines OA, Glass JD, Hoover DR, Bacellar H. HIV dementia. Incidence and risk factors. In: Price RW, Perry SW, eds. HIV, AIDS and the brain. Vol 72. New York: Raven Press, 1994:251-72.
5. Bloom FE, Rausch DM. HIV in the brain: pathology and neurobehavioral consequences. J Neurovirol 1997;3:102-9.
6. Gendelman HE, Ghorpade A, Persidsky Y, et al. The neuropathogenesis of HIV-1 dementia. AIDS 1997;11:S35-45.
7. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-93.
8. Wiley CA, Schrier RD, Nelson JA, Lanpert PW, Oldstone MBA. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 1986;83:7089-93.
9. Nottet HSLM, Gendelman HE. Unraveling the neuroimmune mechanisms for HIV-1 encephalitis. Immunol Today 1995;16:441-8.
10. Wesselingh SL, Power C, Glass JD, et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neural 1993;33:576-82.
11. Nuovo GJ, Gallery F, MacConnell P, Braun A. In situ detection of polymerase chain reaction amplified HTV-1 nucleic acid and tumor necrosis factor alpha RNA in the central nervous system. Am J Pathol 1994;144:659-66.
12. Genis P, Jett M, Beraton EW, et al. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176:1703-18.
13. Schmidtmayerova H, Nottet HSLM, Nuovo G, et al. Human immunodeficiency virus type 1 infection alters chemokine b peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996;93:700-4.
14. Heyes MP, Brew BJ, Martin A, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neural 1991;29:202-9.
15. Adamson DC, Wildemann B, Saski M, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-21.
16. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Cheng-Mayer C, Dubrovsky L, Gendelman HE. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995;181:735-45.
17. Nottet HSLM, Persidsky Y, Sasseville VG, et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 1996;156:1284-95.
18. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 1991;7:111-8.
19. Guilian D, Wendt E, Vaca K, Noonan CA. The envelope glycoprotein of human immunodeficiency virus type I stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci USA 1993;90:2769-73.
20. Savio T, Levi G. Neurotoxicity of HIV coat protein gp120, NMDA receptors, and protein kinase C: a study with rat cerebellar granule cell cultures. J Neurosci Res 1993;34:265-72.
21. Ranki A, Nvberg M, Ovod V, et al. Abundant expression of HIV nef and rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995;9:1001-8.
22. New DR, Ma M, Epstein LG, Nath A, Gelbard HA. Human immunodeficiency virus type 1 tat protein induce death by apoptosis in primary human neuron cultures. J Neurovirol 1997;3:168-73.
23. Griffin DE, Wesselingth SL, McArthur JC. Elevated central nervous system prastaglandins in human immunodeficiency virus-associated dementia. Ann Neural 1994;35:592-7.
24. Gelbard HA, Nottet HSLM, Swindells S, et al. Platelet-activating factor a candidate human immunodeficiency virus type-1-induced neurotoxin. J Viral 1994;68:4628-35.